Immucell Corporation is a biotechnology company that focuses on developing innovative products for the veterinary market, particularly in the areas of animal health and well-being. The company's primary emphasis is on enhancing the immune health of livestock, specifically in dairy and beef cattle, through the advancement of its proprietary products aimed at preventing and treating diseases. Immucell's flagship product is designed to provide passive immunity to newborn calves, promoting overall growth and reducing mortality rates. Through its research and development efforts, the company aims to improve the health management of livestock, contributing to the sustainability of the agricultural industry. Read More
ImmuCell (NASDAQ:ICCC) released second-quarter financial results and hosted an earnings call on Friday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive financial data and
ImmuCell (NASDAQ:ICCC) reported higher second-quarter sales and earnings as domestic demand for its calf scours prevention products increased, while the company outlined plans to invest about $8 million to more than triple manufacturing capacity by the end of 2027.
Product sales rose 11.5% year ove
ImmuCell (NASDAQ:ICCC) reported a record first quarter of 2026, with management saying the company’s narrowed focus on its First Defense calf scours prevention portfolio helped drive its first-ever quarter above $10 million in product sales.
President and Chief Executive Officer Olivier te Boekhors
In a significant strategic shift that marks the end of a multi-year regulatory odyssey, ImmuCell Corporation (Nasdaq: ICCC) announced late yesterday, December 23, 2025, that it has received another Technical Section Incomplete Letter from the U.S. Food and Drug Administration (FDA) regarding its subclinical mastitis treatment, Re-Tain. The letter,
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc., Eli Lilly and Co., and Shopify Inc., as well as a micro-cap stock ImmuCell Corp.
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
